CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma. [electronic resource]

By: Contributor(s): Publication details: American journal of cancer research 2017Description: 1637-1641 p. digitalISSN:
  • 2156-6976
 In: American journal of cancer research vol. 7
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.